leadf
logo-loader
viewNetScientific PLC
(
AIM:NSCIFRA:NTK1
)

NetScientific portfolio firm PDS Biotech sells off New Jersey tax benefits

The company said PDS has received US$4.5mln from the sale of the benefits, which fall under the New Jersey Technology Business Tax Certificate Transfer Net Operating Loss program

NetScientific PLC - NetScientific portfolio firm PDS Biotech sells off New Jersey tax benefits

NetScientific PLC (LON:NSCI) said its portfolio firm, PDS Biotechnology Corp (NASDAQ:PDSB), it which it owns a 5.75% stake, has received US$4.5mln from the net sale of tax benefits to an unrelated, profitable New Jersey corporation pursuant to the company's participation in the New Jersey Technology Business Tax Certificate Transfer Net Operating Loss (NOL) program for 2020.

The NOL program enables qualified, unprofitable NJ-based technology or biotechnology companies with fewer than 225 employees to sell a percentage of net operating losses and research and development (R&D) tax credits to unrelated profitable corporations, allowing qualifying firms with NOLs to turn their tax losses and credits into cash proceeds to fund growth and operations.

"We are pleased to receive an allocation from the New Jersey NOL program. The funding will be beneficial to us as we continue to efficiently utilize our resources to advance our immuno-oncology pipeline through development," PDS president and chief executive Frank Bedu-Addo said in a statement.

"We are pleased at PDS' successful sale of historical losses for a substantial amount. This is a great example of a NetScientific portfolio company using non-dilutive sources of funding to further its growth objectives," added NetScientific chief executive Ilian Iliev.

Shares in NetScientific rose 1.9% to 55p in early deals on Tuesday.

Quick facts: NetScientific PLC

Follow
AIM:NSCI

Price: 113 GBX

Market Cap: £23.7 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

NetScientific invest £1m in Martlet Capital 'fitting with strategy to...

NetScientific PLC (AIM:NSCI, FRA:NTK1) (AIM:NSCI, FRA:NTK1) chief executive, Dr Ilian Iliev joins Proactive after announcing their news to invest an initial £1mln in Martlet Capital, which has been set up to acquire a portfolio of minority interests in growth companies operating in the Cambridge...

6 days, 16 hours ago

2 min read